Legend Biotech's three largest insider shareholders as of August 29, 2026 are Ying Huang (Chief Executive Officer, 247.44K shares), Ying Huang (Chief Executive Officer, 238.49K shares), Patrick John Casey (Director, 48.60K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ying Huang | Chief Executive Officer | 238,490 | 0 | 238,490 | 74.0% | 02 Jul, 2026 |
| 2 | Patrick John Casey | Director | 48,604 | 0 | 48,604 | 15.1% | 02 Jul, 2026 |
| 3 | Alan Bash | Interim Ceo | 35,142 | 0 | 35,142 | 10.9% | 18 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 14 Aug, 2026 | Alan Bash | Interim Ceo | Acquired A | 4,908 | $0.00 | $0 | 35,142 | Direct |
| 30 Jun, 2026 | Patrick John Casey | Director | Disposed S | 6,000 | $14.80 | $88.80K | 48,604 | Direct |
| 30 Jun, 2026 | Ying Huang | Chief Executive Officer | Disposed G | 3,382 | $0.00 | $0 | 238,490 | Direct |
| 25 Jun, 2026 | Ying Huang | Chief Executive Officer | Disposed S | 5,566 | $14.78 | $82.27K | 241,872 | Direct |
| 25 Mar, 2026 | Ying Huang | Chief Executive Officer | Disposed S | 9,936 | $8.77 | $87.14K | 247,438 | Direct |